BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21438902)

  • 21. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
    Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT
    Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.
    Cossu-Rocca P; Eble JN; Delahunt B; Zhang S; Martignoni G; Brunelli M; Cheng L
    Mod Pathol; 2006 Apr; 19(4):488-93. PubMed ID: 16554730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1053-9. PubMed ID: 14559990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma.
    Palmedo G; Fischer J; Kovacs G
    Lab Invest; 1999 Mar; 79(3):311-6. PubMed ID: 10092067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas.
    Zhuang Z; Park WS; Pack S; Schmidt L; Vortmeyer AO; Pak E; Pham T; Weil RJ; Candidus S; Lubensky IA; Linehan WM; Zbar B; Weirich G
    Nat Genet; 1998 Sep; 20(1):66-9. PubMed ID: 9731534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences.
    Kovacs G; Tory K; Kovacs A
    J Pathol; 1994 May; 173(1):39-44. PubMed ID: 7931836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
    Hughson MD; Johnson LD; Silva FG; Kovacs G
    Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Numerical chromosomal aberrations in papillary renal cortical tumors: relationship with histopathologic features.
    Henke RP; Erbersdobler A
    Virchows Arch; 2002 Jun; 440(6):604-9. PubMed ID: 12070600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pax-2 expression in adult renal tumors.
    Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
    Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
    Weiss MM; Snijders AM; Kuipers EJ; Ylstra B; Pinkel D; Meuwissen SG; van Diest PJ; Albertson DG; Meijer GA
    J Pathol; 2003 Jul; 200(3):320-6. PubMed ID: 12845628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three genetic developmental stages of papillary renal cell tumors: duplication of chromosome 1q marks fatal progression.
    Szponar A; Zubakov D; Pawlak J; Jauch A; Kovacs G
    Int J Cancer; 2009 May; 124(9):2071-6. PubMed ID: 19123481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.
    Gronwald J; Baur AS; Holtgreve-Grez H; Jauch A; Mosimann F; Jichlinski P; Wauters JP; Cremer T; Guillou L
    J Pathol; 1999 Feb; 187(3):308-12. PubMed ID: 10398084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trisomy 3 in renal cell carcinoma.
    Renshaw AA; Fletcher JA
    Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
    Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cell carcinoma with extensive clear cell change sharing characteristics of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma.
    Kuroda N; Tamura M; Hes O; Michal M; Kawada C; Shuin T; Lee GH
    Pathol Int; 2009 Sep; 59(9):687-8. PubMed ID: 19712140
    [No Abstract]   [Full Text] [Related]  

  • 37. End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.
    Hes O; Síma R; Nemcová J; Hora M; Bulimbasic S; Kazakov DV; Urge T; Reischig T; Dvorák M; Michal M
    Virchows Arch; 2008 Oct; 453(4):313-9. PubMed ID: 18795325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
    Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
    Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
    Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.